Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geu-Ru Hong

Showing results (231-240 of 259) with videos related to

Pageof 26
Sort By:
Clinical Therapeutics|May 11, 2016
A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential HypertensionJang Hoon Lee, Dong Heon Yang, Jin Yong Hwang, et al.
The American Journal of Cardiology|April 11, 2018
Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial FibrillationOh-Hyun Lee, Jung-Sun Kim, Hui-Nam Pak, et al.
Korean Circulation Journal|December 19, 2023
Comparison of Intracardiac Echocardiography Versus Transesophageal Echocardiography for Guidance During Transcatheter Aortic Valve ReplacementSang-Hyup Lee, Seunguk Oh, Young-Guk Ko, et al.
Frontiers in Cardiovascular Medicine|July 22, 2024
High prevalence of <i>ALPK3</i> premature terminating variants in Korean hypertrophic cardiomyopathy patientsSeung Woo Ryu, Won Chan Jeong, Geu Ru Hong, et al.
Clinical Therapeutics|May 8, 2020
Effectiveness of Fimasartan and Rosuvastatin Combination Treatment in Hypertensive Patients With DyslipidemiaSeung-Jun Lee, Jaewon Oh, Sung-Jin Hong, et al.
The Korean Journal of Internal Medicine|July 1, 2011
Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patientsTae-Hyun Yang, Doo-Il Kim, Dong-Kie Kim, et al.
The Canadian Journal of Cardiology|September 16, 2023
Outcomes of Severe Mitral Stenosis With the Revised Severity Criteria: Mitral Valve Replacement vs Percutaneous Mitral ValvuloplastyDae-Young Kim, Iksung Cho, Kyu Kim, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 13, 2024
Optimizing Percutaneous Mitral Valvuloplasty for Rheumatic Mitral Stenosis - Clinical Significance of Changes in Mitral Valve AreaKyu-Yong Ko, Iksung Cho, Dae-Young Kim, et al.
BMC Medicine|September 6, 2022
Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signalingSeul-Gee Lee, Darae Kim, Jung-Jae Lee, et al.
Journal of Korean Medical Science|May 7, 2024
Shifts in Clinical Characteristics, Treatment, and Outcome for Rheumatic Mitral Stenosis: Insights From a 20-Year Multicentre Registry Study in KoreaHee Jeong Lee, Iksung Cho, Dae-Young Kim, et al.
Pageof 26

Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
Clinical Therapeutics|May 11, 2016
A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential HypertensionJang Hoon Lee, Dong Heon Yang, Jin Yong Hwang, et al.
The American Journal of Cardiology|April 11, 2018
Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial FibrillationOh-Hyun Lee, Jung-Sun Kim, Hui-Nam Pak, et al.
Korean Circulation Journal|December 19, 2023
Comparison of Intracardiac Echocardiography Versus Transesophageal Echocardiography for Guidance During Transcatheter Aortic Valve ReplacementSang-Hyup Lee, Seunguk Oh, Young-Guk Ko, et al.
Frontiers in Cardiovascular Medicine|July 22, 2024
High prevalence of <i>ALPK3</i> premature terminating variants in Korean hypertrophic cardiomyopathy patientsSeung Woo Ryu, Won Chan Jeong, Geu Ru Hong, et al.
Clinical Therapeutics|May 8, 2020
Effectiveness of Fimasartan and Rosuvastatin Combination Treatment in Hypertensive Patients With DyslipidemiaSeung-Jun Lee, Jaewon Oh, Sung-Jin Hong, et al.
The Korean Journal of Internal Medicine|July 1, 2011
Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patientsTae-Hyun Yang, Doo-Il Kim, Dong-Kie Kim, et al.
The Canadian Journal of Cardiology|September 16, 2023
Outcomes of Severe Mitral Stenosis With the Revised Severity Criteria: Mitral Valve Replacement vs Percutaneous Mitral ValvuloplastyDae-Young Kim, Iksung Cho, Kyu Kim, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 13, 2024
Optimizing Percutaneous Mitral Valvuloplasty for Rheumatic Mitral Stenosis - Clinical Significance of Changes in Mitral Valve AreaKyu-Yong Ko, Iksung Cho, Dae-Young Kim, et al.
BMC Medicine|September 6, 2022
Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signalingSeul-Gee Lee, Darae Kim, Jung-Jae Lee, et al.
Journal of Korean Medical Science|May 7, 2024
Shifts in Clinical Characteristics, Treatment, and Outcome for Rheumatic Mitral Stenosis: Insights From a 20-Year Multicentre Registry Study in KoreaHee Jeong Lee, Iksung Cho, Dae-Young Kim, et al.
Pageof 26